Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Collaborative Research Initiative Aims to Cut Drug Development Time in Half

21.01.2004


The Myelin Repair Foundation (MRF), a Saratoga, Calif.-based non-profit research foundation, today announced the formation of a consortium of five of the world’s leading scientists in myelin research. By providing the funding, as well as the business and technology infrastructure to support the collaboration, the Myelin Repair Foundation expects to accelerate the research process and deliver targets for palliative treatments for people living with Multiple Sclerosis (MS) in five years.



Dr. Ben Barres, Professor of Developmental Biology and Neurobiology at Stanford University School of Medicine; Dr. David Colman, Director and Penfield Professor at the Montreal Neurological Institute at McGill University; Dr. Robert Miller, Professor of Neurosciences at Case Western Reserve University; Dr. Stephen Miller, Professor of Microbiology-Immunology at Northwestern University; and Dr. Brian Popko, Professor of Neurology at the University of Chicago, have agreed to a collaborative research plan that links the research activities of these five major university laboratories in conducting the most advanced research on various aspects of myelin--the protective coating surrounding the nerve fibers of the brain and spinal cord. This innovative approach to medical research breaks down traditional barriers to collaboration between labs, and provides for business and scientific oversight boards to guide research toward successful results.

To underwrite this initiative and achieve success in the development of MS treatments, MRF intends to raise a total of $25 million over the next four years.


“Medical research experts, like top scientists in all areas of high technology, must focus very narrowly,” said Scott Johnson, President and Founder of MRF. ” But this kind of siloing is a distinct disadvantage when it comes to complex diseases like MS. To solve multifaceted problems requires coordination among the most accomplished specialists in multiple disciplines. That collaboration between disciplines is what MRF is about,” Johnson continued. “We are honored and grateful to these prestigious scientists for their enthusiasm and commitment to this important project.”



The Myelin Repair Foundation (MRF) is a Northern California-based, non-profit research foundation created to provide a supportive environment in which leading research scientists at multiple universities and experienced business executives can work together to execute a five year research plan – with milestones, parallel experiments, collaboration, and, most important, a constant focus on developing effective treatments for Multiple Sclerosis. Guided by the best practices for building and growing a for-profit company, MRF has created a unique partnership between academic researchers, scientists, and business executives to define an integrated research plan, provide ongoing funding, and coordinate research efforts for maximum productivity.

About Multiple Sclerosis (MS) and Myelin Repair

MS is a degenerative disease of the central nervous system that affects more than 2.5 million people worldwide. The breaking down of myelin, the protective coating surrounding the nerve fibers of the brain and spinal cord, and the body’s inability to repair it, are the result of such central nervous system diseases as MS. By combining their research efforts, MRF scientists expect to develop viable drug targets that restore the body’s natural ability to repair myelin, reversing the effects of MS.

For more information contact:
Ed Murphy at 408-871-2410, ed@myelinrepair.org
or Carol Menaker at 408-927-5164, carol@myelinrepair.org

Ed Murphy | Myelin Repair Foundation
Further information:
http://www.myelinrepair.org
http://www.myelinrepair.org/newsroom

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>